SEC Form 4 · accession 0001070081-17-000102

PTC THERAPEUTICS, INC. · PTCT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Christine Marie Utter

Officer — Principal Financial Officer

Period of report

Jun 2, 2017

Accepted (ET)

Jun 6, 2017 · 6:25 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001070081

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	5,297	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right To Buy)^F1	$13.10	Jun 2, 2017	A	25,000	A	—	Jun 2, 2027	Common Stock	25,000	25,000	D
Stock Option (Right To Buy)^F2	$490.80	holding	—	—	—	—	Apr 27, 2021	Common Stock	74	74	D
Stock Option (Right To Buy)^F2	$218.40	holding	—	—	—	—	Jan 10, 2022	Common Stock	21	21	D
Stock Option (Right To Buy)^F2	$10.85	holding	—	—	—	—	May 15, 2023	Common Stock	1,150	1,150	D
Stock Option (Right To Buy)^F3	$27.05	holding	—	—	—	—	Jan 28, 2024	Common Stock	3,369	3,369	D
Stock Option (Right To Buy)^F4	$40.45	holding	—	—	—	—	Sep 23, 2024	Common Stock	4,688	4,688	D
Stock Option (Right To Buy)^F5	$51.00	holding	—	—	—	—	Jan 2, 2025	Common Stock	17,800	17,800	D
Stock Option (Right To Buy)^F6	$30.86	holding	—	—	—	—	Jan 3, 2026	Common Stock	11,000	11,000	D
Stock Option (Right To Buy)^F7	$11.23	holding	—	—	—	—	Jan 2, 2027	Common Stock	12,600	12,600	D

Explanation of responses

F1This option was granted on June 2, 2017, and vests over two years, with 50% of the shares underlying the option vesting on June 2, 2018, and an additional 12.5% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on September 2, 2018.
F2Currently exercisable.
F3This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 28, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 28, 2015.
F4This option was granted on September 23, 2014 and vests over four years, with 25% of the shares underlying the option vested on September 23, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on December 23, 2015.
F5This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vested on January 2, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2016.
F6This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
F7This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.